The Company plans to develop API (active pharmaceutical ingredients) trade with Chinese, Indian pharmaceutical and chemical companies (sellers) and MENA pharmaceutical companies (buyers).

As the part of our business in the UAE, a new company will be registered in the UAE as the IP (intellectual property) holder for new pharm.registrations (TM, patents, medicinal registrations). All the activities in local MENA (Middle East and North Africa) market. All the procedures stated for the registration of  the IP, for a year or two will be provided by Orient Pharma Tech company.

Since 2005, our Group is involved in consulting in the field of Pharma, the data analytic research and CRO (clinical research organizations) activities worldwide. We contact with the analytic centers in the industry, consulting the partners (pharma companies), contact the regulators (government entities) and clinical research organizations. The estimated turnover for this activity is unclear now but we plan to develop it for our UAE Company.